Do you want to read an article? Please log in or register.
USPSTF Recommendation Against PSA Screening vs. Stage and Cancer-Specific Mortality in Localized Prostate Cancer
Genitourinary Cancer
Related content
Genitourinary Cancer
Stockholm3 Versus Prostate-specific Antigen in Prostate Cancer Screening: 9-year Outcomes Demonstrating Improved Detection of Aggressive Cancers and Reduced Overdiagnosis from the STHLM3 Trial
Eur Urol
Vigneswaran HT, Palsdottir T, Micoli C, Tilki D, Lin D, Cooperberg M, Eggener S, Falagario UG, Möller A, Aly M, Akre O, Wiklund P, Egevad L, Grönberg H, Nordström T, Eklund M
doi: 10.1016/j.eururo.2025.10.001
COMMENTED
Genitourinary Cancer
Persistent Prostate-Specific Antigen Following Radical Prostatectomy for Prostate Cancer and Mortality Risk
★ 1
Recommended and commented by
Prof. Dr Richard Cathomas, Faculty Member
JAMA Oncol
Tilki D, Chen MH, Wu J, Huland H, Graefen M, Trock BJ, Han M, D'Amico AV
doi: 10.1001/jamaoncol.2025.0110
Genitourinary Cancer
The Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Assessment of Local Recurrence and Distant Metastases in Patients with Biochemical Recurrence of Prostate Cancer After Definitive Treatment: A Systematic Review and Meta-analysis
Eur Urol
Mazzone E, Thomson A, Chen DC, Cannoletta D, Quarta L, Pellegrino A, Gandaglia G, Moon D, Eapen R, Lawrentschuk N, Montorsi F, Siva S, Hofman MS, Chiti A, Briganti A, Perera ML, Murphy DG
doi: 10.1016/j.eururo.2025.05.006
Breast Cancer
Improved stage-specific survival in screen-detected breast cancer in Denmark: a cohort study
J Natl Cancer Inst
Tickle A, Offman J, North B, Jørgensen SF, Njor S, Sasieni P
doi: 10.1093/jnci/djaf377
Genitourinary Cancer
A Comprehensive Systematic Review and Meta-analysis of the Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Diagnosis and Primary Staging before Definitive Treatment
Eur Urol
Mazzone E, Cannoletta D, Quarta L, Chen DC, Thomson A, Barletta F, Stabile A, Moon D, Eapen R, Lawrentschuk N, Montorsi F, Siva S, Hofman MS, Chiti A, Murphy DG, Briganti A, Perera ML
doi: 10.1016/j.eururo.2025.03.003
Further Publications
LATE-STAGE OUTCOMES AS SURROGATES FOR MORTALITY IN CANCER SCREENING TRIALS: A SYSTEMATIC REVIEW AND META-ANALYSIS
Cancer Epidemiol Biomarkers Prev
Rebolj M, Brentnall AR, Geppert J, Kouppa N, Shinkins B, Freeman K, Stinton C, Randell MJ, Johnson S, Smith RA, Sasieni P, Janes SM, Etzioni R, Duffy SW, Taylor-Phillips S
doi: 10.1158/1055-9965.EPI-25-0201
Genitourinary Cancer
Association Between the PRIMARY Score at Staging Prostate-specific Membrane Antigen Positron Emission Tomography and Overall Survival Among Patients with Newly Diagnosed Prostate Cancer: Findings from the International, Multicenter PROMISE Registry
Eur Urol
Karpinski MJ, Hoberück S, Fendler WP, Civan C, Bundschuh RA, Thomas C, Bjartell A, Trägårdh E, Soeterik TFW, Evangelista L, Vondrak A, Rasul S, Forner L, Giorgio AD, Scholtissek H, Miksch J, Holzgreve A, Lanfranchi F, Rahbar K, Hofman MS, Rauscher I, Güven O, Eiber M, Ayati N, Umutlu L, Herrmann K, Hadaschik B, Emmett L
doi: 10.1016/j.eururo.2025.10.013
Lung, Respiratory and Thoracic Cancer
Stage- and histology-specific sensitivity for the detection of lung cancer of the NELSON screening protocol-A modeling study
Int J Cancer
de Nijs K, Ten Haaf K, Hubert J, Moldovanu D, van der Aalst CM, Groen HJM, de Jong PA, Heuvelmans MA, Oudkerk M, de Koning HJ
doi: 10.1002/ijc.70045
Genitourinary Cancer
Salvage Focal Therapy vs Radical Prostatectomy for Localized Radiorecurrent Prostate Cancer
JAMA Oncol
Light A, Peters M, Arya M, Bertoncelli Tanaka M, Dudderidge T, Emara A, Emberton M, Grey A, Hindley R, Laniado M, McCraken S, Moore CM, Nigam R, Noureldin M, Orczyk C, Reddy D, Virdi J, Ahmed M, Albisinni S, Cathcart P, Joniau S, Karnes RJ, Persad R, Rajwa P, Sanchez-Salas R, Shariat SF, Smith JA, Tilki D, van der Poel H, Calleris G, Gontero P, Marra G, Ahmed HU, Shah TT
doi: 10.1001/jamaoncol.2025.6448